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070: Neural tube defects in India occur despite normal
maternal folate status and low frequency of T allele
at C677T polymorphism in the MTHFR gene
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India has a high projected burden of Neural tube defects (NTDs) and
incidence in some states is reported to be as high as 11.4/1,000 births.
Despite this, no study has systematically probed into the nutritional or
genetic etiology of NTDs. We present an interim report of our 3-year,
multi-center case-control study funded by the Department of Bio-
technology to investigate the genetic susceptibility to neural tube
defects and its association with maternal vitamin B12 and folate status
involving subjects from four cities in four different states.
During the period of January 2007–May 2008, 132 NTD case trios
(offspring and both parents) were enrolled. Plasma folate concentrations
were normal (more than 7 nmol/l) in 93.5% mothers, while 36.7% had
low (less than 150 pmol/l) plasma vitamin B12 concentration and 45.6%
had hyperhomocysteinemia (more than 10 mmol/l). Folate deficiency
contributed only 4.6% to the risk of hyperhomocysteinemia while vitamin
B12 deficiency contributed 29.73% (population attributable risk). Fre-
quency of the risk allele ‘T’ at the C677T polymorphism was 13.3% in
mothers with NTD fetuses and 13.4% in control mothers. The homozy-
gous TT genotype was present in two cases and control fetuses each but in
none of the mothers in the study. No evidence of preferential transmission
of the T allele to the affected fetus from mothers was noted.
Our results suggest for the first time that folate deficiency and the
predisposing MTHFR C677T polymorphism has a limited contribu-
tion to the etiology of NTDs in India. Thus, it may be important to
look beyond folate and MTHFR C677T polymorphism for exploring
the etiology of NTDs in India. We will have an opportunity to study
whether vitamin B12 deficiency contributes to this problem and also
to study the role of gene–gene and gene–nutritional interaction.
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Individual differences in personality were reported to be influenced by
both environmental and genetic factors. Psychobiological model pro-
posed by Cloninger supposes that sociability related personality traits
are mediated by dopaminergic system functioning. It has been accepted
now that complex phenotypes, such as personality traits, are presum-
ably affected by the interaction of multiple genes of small effect. Such
factors as age, ethnicity and gender, cultural and environmental con-
ditions could also contribute into variation of personality. We aimed to
define a possible epistasis of DRD2 TaqIA and SLC6A3 MspI poly-
morphisms, considering gender and ethnicity as confounding factors,
on personality traits (assessed with the EPI and TCI questionnaires) via
linear regression analyses. We recruited 602 healthy individuals (men-
206, women-396) of Caucasian origin (Russians-214, Tatars-388) from
Russia (mean age ± SD, 19.85 ± 2.43 years). In the present study
gender and ethnicity differences in personality were observed: women
scored significantly higher on Neuroticism, Novelty Seeking (NS),
Harm Avoidance (HA) and Reward Dependence compared to men;
Russians reported higher scores on Extraversion and NS scale, while
Tatars revealed higher HA. Although both DRD2 TaqIA and SLC6A3
MspI polymorphisms might be involved in dopaminergic activity reg-
ulation, gene–gene interaction has not been demonstrated. However,
DRD2 and SLC6A3 gene effects were revealed in relation to Neuroti-
cism (F = 19.10; P \ 0.0001) and NS (F = 13.97; P \ 0.0001)
correspondingly, while adjusting for such confounding factors as gen-
der and ethnicity, explaining 8.5 and 6.6% of variation in these
personality traits. On the other hand, we observed SLC6A3 main effect
on NS (F = 4.15; P = 0.042) and Persistence (F = 5.40; P = 0.020)
contributing to 0.5 and 0.7% of variation, correspondingly. Since DRD2
TaqIA A1-allele has been reported to result in decreased dopaminergic
activity, our findings allow supposing that dopamine excess in synapse
could predispose to enhanced anxiety-related traits. Since regression
models involving DRD2 and SLC6A3 genes were demonstrated to
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influence different personality traits, polygenic cause of personality was
approved indicating that a single neurotransmitter in a some extent can
influence multiple personality traits. This work was supported by
Russian foundation for humanities grants (06-06-00163a, 08-06-
00579a) and Russian Science Support Foundation (to A.Kazantseva,
D.Gaysina).
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Parkinson’s disease (PD), the second most common neurodegenera-
tive disorder, affecting at least 1% of the population over the age of
60 years. A total of 10 loci and eight causal genes have been iden-
tified for PD. Among the identified genes largest number of mutations
has been detected in Parkin gene. In this study, a total of 384 PD
patients, with the mean age of onset being 48 ± 13 (age range,
5–78 years), and 105 controls were recruited for the study from
eastern India. Mutations were screened in Parkin by amplification of
exons along with the flanking splice junctions by polymerase chain
reaction, single stranded conformation polymorphism and DNA
sequencing. A total of 21 nucleotide variants were detected in Parkin
gene of PD patients; these include six nonsynonymous changes
(Gln34Arg, Arg42Cys, Arg42His, Tyr143Cys, Arg334Cys and
Gly359Asp) in heterozygous condition and two homozygous dele-
tions encompassing exons 3 and 4, and exons 8 and 9, in two
unrelated families. Mutation in Parkin was identified in 7.55% cases.
Two Parkin coding polymorphisms, Ser167Asn (rs1801474) and
Val380Leu (rs1801582), reported to be associated with PD in dif-
ferent populations but with variable results, were found to be
significantly associated with PD cases in our cohort independent of
age of onset and sex. This study is supported by a grant from Council
and Scientific Research (CSIR), Govt. of India.
073: PAX6 interacts with SPARC, Ras and P53
that links Akt and TGFbeta pathways and influences
on neural functions in brain
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The PAX6 is one of the critical transcriptional regulators for the
development of brain, eyes, islets of pancreas. The involvement of
PAX6 in neural development is well known but the knowledge about
its interaction with other proteins during development and disease is
limited. Predicting interaction of PAX6 like any other protein with
specificity is largely an unsolved problem. It is also not clear how
mutation of the PAX6 gene results in various phenotypes and why the
phenotypes are of variable expressivity. We explore PAX6 interactors
through co-immunoprecipitation. It was interesting to observe a ma-
tricellular protein, SPARC, interacting with PAX6. Immunoreactive
bands with Ras and P53 were also detected in the sample of brain
immunoprecipitated with anti-PAX6. We also present models of
PAX6 interacting protein through on-line servers STRING and PIP.
This article elucidates putative interaction network of PAX6. It also
provides insight to associated proteins in the cascade of hierarchy of
PAX6 transcription factor. It is presumed that PAX6 interacts with
SPARC, Ras and P53 that links Akt and TGFbeta pathways and
influences on neural functions in brain.
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degeneration among Indian patients
1Inderjeet Kaur, 1Saritha Katta, 1Avid Hussain, 2Retina Research
Group, 1Subhabrata Chakrabarti
1Kallam Anji Molecular Genetics Laboratory, HERF, L V Prasad Eye
Institute, Road# 2 Banjara Hills, AP, India, 2Smt Kanuri Retina
Vitreous Centre, HEI, L V Prasad Eye Institute, Road# 2 Banjara
Hills, AP, India
Objectives: Single nucleotide polymorphisms (SNPs) in the ARMS
(LOC387715) (rs10490924), HTRA1 (rs11200638) and CFH
(rs1061170) genes have been implicated in age-related macular degen-
eration (AMD). The present study was undertaken to understand the
involvement of the ARMS2 and HTRA1 in an AMD cohort from India.
Methods: The coding region of ARMS2 (exon I) and the promoter of
HTRA1were screened by resequencing in AMD cases (n = 250) and
normal controls (n = 250). Odds ratios were calculated to assess the
risk of individual genotypes. Linkage disequilibrium (LD) and hap-
lotype frequencies were estimated with Haploview software.
Population attributable risk (PAR%) for the associated SNPs and their
combined effects were calculated. Meta analysis of the associated
SNPs was done across different studies.
Results: Significant associations were noted with the risk alleles of
rs10490924 (‘T’ allele; P = 5.34 9 10–12) in ARMS2, and
rs11200638 (‘A’ allele; P = 4.32 9 10–12) and rs2672598 (‘C’
allele; P = 3.39 9 10–11) in HTRA1 amongst the cases. Corre-
spondingly, the homozygous risk genotypes ‘TT’, ‘AA’ and ‘CC’ in
these SNPs exhibited higher disease odds and PAR%. The rs10490924
and rs11200638 were in tight LD (D’ = 0.90, 95%CI 0.84–0.93). The
‘G-C-T-A-C’ was the risk haplotype (P = 8.04 9 10–15), while the
‘G-C-G-G-T’ haplotype was protective (P = 2.01 9 10–4). The
combined effect of CFH (CC) and ARMS2 (TT) risk genotypes
exhibited a PAR of 93.7% (OR = 73.89, 95%CI, 8.69–628.13). Meta
analysis reinforced the earlier findings that the rs10490924 (ARMS2)
risk genotype TT contributed to an increased risk of AMD (pooled
OR = 8.13, 95%CI, 6.82–9.68) compared to a single copy (pooled
OR = 2.47, 95%CI, 2.23–2.74) of the risk (T) allele.
Conclusions: The ARMS2 (rs10490924) SNP conferred a higher
susceptibility to AMD than the HTRA1 SNPs, as evident from
genotype, haplotype and Meta analysis. Overall, these results under-
score the functional importance of these SNPs in AMD pathogenesis
and provide their risk estimates in the Indian cohort that may be
useful for predictive testing.
075: In Silico analysis reveals Pyrroloquinoline quinine
is an effective ligand for a-synuclein: a key player
in Parkinson’s disease
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Alpha-synuclein is a member of the synuclein family, which also
includes beta- and gamma-synuclein. Synucleins are abundantly
expressed in the brain and alpha- and beta-synuclein inhibit
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phospholipase D2 selectively. SNCA may serve to integrate presyn-
aptic signaling and membrane trafficking. Three novel mis-sense
mutations as well as gene triplication genetically link the 140-residue
protein—synuclein at A30P (VAR_007957), E46K (VAR_022703)
and A53T (VAR_007454) believed to cause Familial Early-Onset
Parkinson’s Disease. Analysis of the SNCA exon showed a GCA to
CCA nucleotide substitution in codon 134, GAG to AAG nucleotide
substitution in codon 182 and GCA to ACA, nucleotide substitution in
codon 203 of the SNCA gene, causing amino acid substitutions of Ala
to Pro (A30P), Glu to Lys (E46K), and Ala to Thr (A53). These point
mutations show heterozygosity and have definite roles in determining
protein secondary structure conformation and abnormal folding of
non-beta amyloid protein, whose function is unclear but thought to be
involved in neuronal degeneration causing a loss of dopamine syn-
thesis. Homology modeling of three variants shows slight difference in
Ramachandran plot values at corresponding mutated residues which
provide valuable information about their structural backbone orien-
tation. It was shown that neither the A53T nor the A30P mutation has a
significant effect on the structure of the folded protein, although the
A30P mutation may cause a minor perturbation in the helical structure
around the site of the mutation. a-Synuclein is a Parkinson’s-disease-
related protein. It forms aggregates in vivo, and these aggregates cause
cell cytotoxicity. Aggregation inhibitors are expected to reduce a-
synuclein cytotoxicity, and an aggregation accelerator has recently
been reported to reduce a-synuclein cytotoxicity. Agents that prevent
the formation of amyloid fibrils might allow a novel therapeutic
approach to PD. The results of the current study indicate that Pyrrol-
oquinoline quinine and its derivatives might serve as effective ligands
for alpha-synuclein thus reducing its cytotoxic effects.
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